ARCORAL PHARMA AS

3425 REISTAD

Finances

Share Ownership

Return on Equity

−2,46 %

Current Ratio

33,62

Debt-to-Equity Ratio

0,16

Key figures (NOK)	2022	2021	2020	2019
Revenue	0	0	2 000	0
Net Income	−9 000	−14 000	−666 000	−311 000
Total Assets	437 000	464 000	1 722 000	3 877 000
Total Equity	366 000	375 000	390 000	1 935 000

Income (NOK)	2022	2021	2020	2019
Revenue	0	0	2 000	0
Expenditure	12 000	18 000	788 000	479 000
Operating Profit	−12 000	−18 000	−786 000	−479 000
Financial Income	0	0	5 000	74 000
Financial Costs	0	0	73 000	0
Financial Balance	0	0	−68 000	74 000
Earnings Before Tax	−12 000	−18 000	−854 000	−405 000
Tax	−3 000	−4 000	−188 000	−95 000
Net Income	−9 000	−14 000	−666 000	−311 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	0	0	0	0
Total Current Assets	437 000	464 000	1 722 000	3 877 000
Total Assets	437 000	464 000	1 722 000	3 877 000
Total Retained Equity	−212 000	−203 000	−188 000	1 357 000
Total Equity	366 000	375 000	390 000	1 935 000
Total Long-Term Debt	58 000	73 000	91 000	1 521 000
Total Current Debt	13 000	16 000	1 242 000	421 000
Total Equity and Debt	437 000	464 000	1 722 000	3 877 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	0	0	0	0
Other Income	0	0	2 000	0
Revenue	0	0	2 000	0
Cost of Goods Sold	0	0	399 000	0
Salary Costs	0	0	0	0
Depreciation	0	0	0	0
Impairment	0	0	0	0
Expenditure	12 000	18 000	788 000	479 000
Operating Profit	−12 000	−18 000	−786 000	−479 000
Financial Income	0	0	5 000	74 000
Financial Costs	0	0	73 000	0
Financial Balance	0	0	−68 000	74 000
Dividends	0	0	880 000	0
Net Income	−9 000	−14 000	−666 000	−311 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	0	0	0	0
Total Tangible Assets	0	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	0	0	0	0
Stock	0	0	0	0
Total Investments	0	0	0	2 084 000
Cash, Bank	437 000	459 000	1 701 000	1 765 000
Total Current Assets	437 000	464 000	1 722 000	3 877 000
Total Assets	437 000	464 000	1 722 000	3 877 000
Total Equity	366 000	375 000	390 000	1 935 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	58 000	73 000	91 000	1 521 000
Creditors	1 000	2 000	0	135 000
Unpaid Taxes	0	0	0	0
Dividends	0	0	880 000	0
Other Current Debt	0	0	0	0
Total Current Debt	13 000	16 000	1 242 000	421 000
Total Equity and Debt	437 000	464 000	1 722 000	3 877 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−2,46 %	−3,73 %	−170,77 %	−16,07 %
Debt-to-Equity Ratio	0,16	0,19	0,23	0,79
Operating Profit Margin	-	-	−39 300 %	-
Current Ratio	33,62	29	1,39	9,21
Quick Ratio	33,62	29	1,39	9,21
Equity Ratio	0,84	0,81	0,23	0,5
Gross Profit Margin	-	-	−19 850 %	-